Related Experiment Video
Updated: May 24, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Prehypertension - time to act
Preeti Gupta1, Shankar Prasad Nagaraju, Ankur Gupta
1Central Government Health Scheme, New Delhi, India.
Insights
Prehypertension, defined as blood pressure between 120/80 and 139/89 mmHg, significantly increases cardiovascular risks. Lifestyle changes are recommended for all patients, with medication for those with comorbidities.
Area of Science:
- Cardiology
- Public Health
- Preventive Medicine
Background:
- Prehypertension, characterized by systolic blood pressure (SBP) 120–139 mmHg and/or diastolic blood pressure (DBP) 80–89 mmHg, is widely recognized.
- Individuals with prehypertension face a substantially elevated risk of developing hypertension and experiencing cardiovascular events compared to normotensive individuals.
- Prehypertensive individuals often present with other cardiovascular risk factors, including obesity, and are prone to premature cardiovascular disease.
Purpose of the Study:
- To highlight the increased cardiovascular risks associated with prehypertension.
- To discuss the unresolved management strategies for prehypertension.
- To emphasize the role of lifestyle modifications and pharmacological interventions in managing prehypertension.
Main Methods:
- Literature review and synthesis of existing data on prehypertension.
- Analysis of epidemiological studies linking prehypertension to cardiovascular outcomes.
- Evaluation of current clinical recommendations for prehypertension management.
Main Results:
- Prehypertension is associated with a 3-fold increased likelihood of developing hypertension.
- Patients with prehypertension exhibit approximately double the rate of cardiovascular events compared to those with normal blood pressure.
- Lifestyle modification is proven effective in reducing cardiovascular event rates in prehypertensive individuals.
Conclusions:
- Lifestyle modification is the cornerstone of management for all prehypertensive patients.
- Pharmacological therapy is reserved for prehypertensive patients with specific comorbidities like diabetes, chronic kidney disease, or coronary artery disease.
- Effective management of prehypertension is crucial for preventing progression to hypertension and reducing long-term cardiovascular morbidity.
Abstract:
The term "prehypertension" defined as systolic blood pressure between 120 and 139 mmHg and/or diastolic pressures between 80 and 89 mmHg has now gained general acceptance. Prehypertension is associated with ~3-fold greater likelihood of developing hypertension, and roughly twice the number of cardiovascular events, than BP < 120/80 mmHg. When compared with normotensive individuals, prehypertensive individuals are more likely to be overweight and obese, to have other cardiovascular risk factors, to progress to established hypertension, and to experience premature clinical cardiovascular disease. The major unresolved issue is the appropriate management of such patients. Lifestyle modification is recommended for all patients with prehypertension as it effectively reduces rate of cardiovascular events. Presently pharmacological therapy is indicated for some patients with prehypertension who have specific comorbidities, including diabetes mellitus, chronic kidney disease, and coronary artery disease.
Related Concept Videos
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology